Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01351454 · ClinicalTrials.gov registry record · NA
Behavioral Depression Treatment for African American HIV-infected Substance Users
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT01351454 is a NA study that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 61 participants.
The verdict
NCT01351454, a NA study, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
The objective of the current study is to test a novel, behavioral approach to treat depressive symptoms and improve HIV medication adherence and subsequent physical health outcomes among African American HIV-infected substance users residing in inner-city Washington, DC. This treatment will serve as a compliment to standard residential and follow-up outpatient substance use treatment, with the goal of reducing depressive symptoms and improving HIV medication adherence, physical health, and substance use outcomes.
Interventions
- BEHAVIORAL ACT HEALTHY
- BEHAVIORAL Nondirective Therapy (NDT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2008-09 |
| Est. Completion | 2013-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01351454
The ClinicalTrials.gov registry entry for NCT01351454 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ACT HEALTHY is the first listed.
NCT01351454 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01351454 about?
NCT01351454 is a clinical study titled "Behavioral Depression Treatment for African American HIV-infected Substance Users". The objective of the current study is to test a novel, behavioral approach to treat depressive symptoms and improve HIV medication adherence and subsequent physical health outcomes among African American HIV-infected substance users residing in inner-city Washington, DC. This treatment will serve as...
What is the current status of trial NCT01351454?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2008-09. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01351454?
The interventions under investigation include: ACT HEALTHY (BEHAVIORAL), Nondirective Therapy (NDT) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01351454?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.